Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report

Marilena Crescimanno, Carla Flandina, Gaetano Leto, Lorena Incorvaia, Fabio Fulfaro, Giuseppe Badalamenti, Lorena Incorvaia, Maria Vittoria Sepporta, Chiara Ancona, Giuseppe Badalamenti, Carla Flandina, Fabio Fulfaro, Marilena Crescimanno, Gaetano Leto, Chiara Ancona

Risultato della ricerca: Articlepeer review

14 Citazioni (Scopus)

Abstract

This study was directed to assess the clinical impact of the circulating cathepsin L, cystatin C, activin A, and follistatin in breast cancer patients. The serum concentrations of these molecules were determined by immunoenzymatic assays, and their association with some clinico-pathological parameters of breast cancer progression was evaluated. Our results identified cystatin C and activin A as predictive markers for the presence of breast cancer and bone metastasis, respectively. Therefore, these proteins may have a clinical role as circulating biomarkers in the diagnosis and therapeutic monitoring of breast cancer patients.
Lingua originaleEnglish
pagine (da-a)415-423
Numero di pagine9
RivistaCancer Investigation
Volume34
Stato di pubblicazionePublished - 2016

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2730???
  • ???subjectarea.asjc.1300.1306???

Fingerprint

Entra nei temi di ricerca di 'Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report'. Insieme formano una fingerprint unica.

Cita questo